相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients
Finola M. Bruins et al.
JAMA DERMATOLOGY (2020)
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis
Linda Stein Gold et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL)
J. Seneschal et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Clinical Goals and Barriers to Effective Psoriasis Care
Bruce E. Strober et al.
DERMATOLOGY AND THERAPY (2019)
Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
T. Joseph Mattingly et al.
PHARMACOECONOMICS (2018)
Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study
C. Paul et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2016)
Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use
Junko Takeshita et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Combining Biologic TherapiesWith Other Systemic Treatments in Psoriasis Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation
April W. Armstrong et al.
JAMA DERMATOLOGY (2015)
Psoriasis prevalence among adults in the United States
Tara D. Rachakonda et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States Findings From the National Psoriasis Foundation Surveys, 2003-2011
April W. Armstrong et al.
JAMA DERMATOLOGY (2013)
Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis
Amanda Robinson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study
D. Thaci et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
A classification of psoriasis vulgaris according to phenotype
C. E. M. Griffiths et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Current severe psoriasis and the Rule of Tens
AY Finlay
BRITISH JOURNAL OF DERMATOLOGY (2005)
Psoriasis: epidemiology, clinical features, and quality of life
RGB Langley et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
分享论文
